Bioactive-Loaded Nanomedicine for the Management of Health and Disease

The new book focuses on the use of natural active substances and nutraceuticals in nano-research for improved healthcare management and applications. It explores advanced nanomaterials that can be utilized for the encapsulation of nutrients, vitamins, and phytoconstituents for the treatment of cancer, psychotic and manic disorders, and chronic inflammation, such as arthritis and psoriasis, as well as for other healthcare issues, such as skin diseases and skin care, atherosclerosis, and more. The chapters discuss the remarkable advantages of using new bioactive and nutraceutical drugs, which offer improved solubility, bioavailability, simultaneous drug delivery, safety extension, long-term delivery, better dissemination of tissue macrophages, security against toxicity, increase in pharmacological activity, and enhanced physical and chemical protection.

Mahfoozur Rahman, PhD, is Assistant Professor at the Department of Pharmaceutical Sciences at Sam Higginbottom University of Agriculture, Technology & Sciences, India. His research focuses on development and characterization of nanosized drug delivery systems for inflammatory disorders. To date, he has published over 100 publications in peer-reviewed journals as well as book chapters, books, and articles in international magazines. He is also a guest editor for several journals.

Sarwar Beg, PhD, is Assistant Professor at the School of Pharmaceutical Education and Research, Jamia Hamdard (Hamdard University), New Delhi, India. He has nearly a decade of experience in systematic development and characterization of novel and nanostructured drug delivery systems using QbD paradigms, including design of experiments (DoE) and quality risk management (QRM). He has published review/research journal articles, book chapters, books, and journal special issues.

Khalid S. Alharbi, PhD, is Assistant Professor in the Department of Pharmacology, College of Pharmacy, Jouf University, Sakakah, Saudi Arabia. His major area of research is cancer, focusing on drug discovery, nanomedicine, and preclinical pharmacological and toxicological studies of anticancer agents. He has published several articles in peer-reviewed journals and has presented papers at numerous international conferences.

Waleed Hassan Almalki, PhD, is Professor of Pharmacology at the College of Pharmacy, Umm Al-Qura University, Makkah, Saudi Arabia. His research is focused on host-virus networks in Hepacivirus C disease progression and host-virus genes expression during oxidative stress, hepatic steatosis, fibrosis, and hepatocellular carcinoma. He has published on HCV pathogenesis and treatment and drug designing, as well as angiogenesis, pharmacological assays, and infectious disease epidemiology.

Nabil K. Alruwaili, PhD, is Assistant Professor and Chairman of the Pharmaceutics Department at the School of Pharmacy, Jouf University, Saudi Arabia. Previously, he worked at the Saudi Food and Drug Authority (SFDA) in product evaluation and standards-setting administration. He has several published articles and has presented papers at international and national scientific conferences.

Majed Al Robaian, PhD, is Dean of the Faculty of Pharmacy at Taif University in Saudi Arabia. He was previously Director of Pharmacy at King Abdulaziz Hospital. He is also a Science Faculty Ambassador for Strathclyde University, UK, and a member of several committees of the Saudi Commission for Health Specialties. His research interests focus on the delivery of therapeutic genes for the treatment of cancer.